CA1121729A - Citrate or lactate or tartrate of alkylene-ols in aqueous antiperspirant - Google Patents
Citrate or lactate or tartrate of alkylene-ols in aqueous antiperspirantInfo
- Publication number
- CA1121729A CA1121729A CA000324948A CA324948A CA1121729A CA 1121729 A CA1121729 A CA 1121729A CA 000324948 A CA000324948 A CA 000324948A CA 324948 A CA324948 A CA 324948A CA 1121729 A CA1121729 A CA 1121729A
- Authority
- CA
- Canada
- Prior art keywords
- lactate
- antiperspirant
- citrate
- composition
- aluminum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
Abstract
27,401 ABSTRACT OF THE DISCLOSURE
Antiperspirant roll-on compositions in general and, in particular, antiperspirant roll-on compositions containing a lactate, citrate, or tartrate ester of an alkylene diol or triol to provide enhanced antiperspirant efficacy.
Antiperspirant roll-on compositions in general and, in particular, antiperspirant roll-on compositions containing a lactate, citrate, or tartrate ester of an alkylene diol or triol to provide enhanced antiperspirant efficacy.
Description
The invention relates to impxoved antiperspirant roll-on compositions in general and, in particulax, to antiperspirant roll-on ccmpositions containing a lactate, cltrate, or taxtrate ester of an alkylene diol or triol to provide enhanced antiperspirant efficacyO
Antipexspirant xoll-on compositions generally col~tain an aluminum or aluminumrzirconium salt as active astringents. Emollients may include liquid fatty acid esters, silicones, minercil oil, propoxylated alcohols, etc., which tend to coat the particle of the astringent material when the product dries in the axilla on evaporation of water into the air or passage into the epidermis, preventing subsequent water of perspiration from permeating thru to activate the astringent. m is results in delayed onset of activity.
~he present invention provides an aqueous antiperspirant c~nposi-tion comprising from about 15 to 25 percent by weight of an astringent ; material and from about 0.5 to 71 percent by weight of a lactate, citrate or tartrate ester of an cilkylene diol or triol.
In a preferred emkodiment, roll-on antiperspirant compositions are provided which comprise about 15 to 25 weight percent of an aluminum or aluminum-zirconium salt and about 0.5 to 71 weight percent of a lactate, citrate, or tartrate ester of an alkylene diol or triol, thereby improving the permeability of moisture through the normally difficultlypermeable coating surrounding the astringent particle.
The incorporation of the esters of the invention into the roll-on formuLations ~rov.ides faster on æ t of antiperspirant activity and higher maKumum efficacy at the 22-hour check point in clinical testiny, probably because the esters have a high dielectric constant, permitting moisture to more readily permeate -the coating around the astringent material. The esters are water so].uble, thereby el.iminating the need for emulsification, dispersing or solubilization. TfliS provides faster onset of activity and yet provides a dr.i.er Eeeling on the skin than with con~entional emollients.
The compositionSar.e nonstaining, less tacky, quick drying, and provide a desirable residual feelO With the proper choice of ingredient~s a nonwhiten-~2~72 ..
iny residue can be ohtained.
The antiperspirant roll-on comr positions contain a citrate, lactate, or tartrate ester of an alkylene diol or triol. r~hese esters include:
1,3-propylene glycol monolactate 1,3-propylene glycol dilactate 1,3-propylene glycol m~nocitrate 1,3-propylene glycol dicitrate 1,3~propylene glycol monotartrate 1,3-propylene glycol ditartrate 1,3-butylene glycol monolactate 1,3-butylene glycol dilactate 1,3-butylene glycol m~nocitrate 1,3-butylene glycol dicitrate 1,3-butylene glycol monotartrate 1,3-butylene glycol ditartrate glycerol monolactate glycerol dilactate glycerol ~onocitrate glycerol dicitrate glycerol monotartrate glycerol ditartrate glyceLol tritartrate, and the lik~.
The lactate esters are preferred becauæ of their more ready availability and ease of manufacture.
Active astrinyents may include ac~leous solutions of alum m um sulfate, al~num chloride, al~Nnum chlorohydrate, l .
or aluminum-zirconium hydroxy chloride. Combinations of aluminum chlorohydrate and al~inum chloride may also be used~
The preferred astringent is aluminum chlorohydra~e.
The esters of -the invention may be used in combina-tion with small amounts (0.5-8 weight percent) of other, more conventional emollients, or functional additives which may be added for reasons other than antiperspirant efficacy, such as thickeners, viscosity stabilizers, ~ragrance solubilizers, opacifiers, etc.
The compositions may also contain ethoxylated fatty alcohols, such as ethoxylated ~tearyl alcohol or ethoxylated stearic acid~ or ethoxylated cetyl or lauryl alcohol, or com-b~nations thereof, containing lO0 to 200 moles of combined ethylene oxide. Those containing high ethylene oxide content tend to be more permeable to moisture, thus further increasing antiperspirant onset and efficacy. The lower ethoxylated com-pounds, i.e., containing about 100 moles of ethylene oxide, are preferred. However, the esters of the invention may be used without the highly ethoxylated materials.
7~
Example 1 A roll~on composition was prepared havin~J the fol~
lowing ingredients:
Parts ~ Wei~ht Glyceryl monostearate 2.15 100 POE stearic acid 3.23 Magnesium aluminum silicate; acid stable 1.00 Aluminum chlorohydrate ~50% aqueous solution) 50.00 1,3-Propylene glycol monolactate 9.30 Fragrance 0-30 Dye color 0.02 Water 34.00 100. 00 *100 POE stearate is stearic acid : 15 ethoxylated with 100 moles of ethylene oxide.
, 7 ~ ~
F.xample 2 Roll-on antiperspirant formula~ions are prepared as follows:
Par~s by Wei~ht A B
Glyceryl monostearate 5.00 3.50 Magnesium aluminum silicate 0.50 1.00 100 POE stearyl alcohol5.00 3.50 Aluminum chlorohydrate (50%) 30.00 48.00 4 POE lauryl alcohol* 1.50 0.50 23 POE stearyl alcohol**4.50 1.50 Fragrance 1.00 0.00 1,3-Propylene glycol monolactate 8.00 ----1)3-Butylene glycol monolactate ---- 10.00 Water 44.50 32 00 100.00100.00 *lauryl alcohol condensed with an a~erage of ~ moles of ethylene oxide **stearyl alcohol condensed with an average of 23 moles o ethylene oxide . . ~ .
Example 3 Parts ~ Welght PPG stearyl ether (2) 4.70 PO~-2-stearyl ether 1.00 Alqminum chlorohydrate (50%) 50 00 POE-100 stearyl ether 1.00 Fragrance 0.30 - 1,3-Propylene glycol monolactate 20.00 Water 23.00 10~. 00 . , ,. .
Antipexspirant xoll-on compositions generally col~tain an aluminum or aluminumrzirconium salt as active astringents. Emollients may include liquid fatty acid esters, silicones, minercil oil, propoxylated alcohols, etc., which tend to coat the particle of the astringent material when the product dries in the axilla on evaporation of water into the air or passage into the epidermis, preventing subsequent water of perspiration from permeating thru to activate the astringent. m is results in delayed onset of activity.
~he present invention provides an aqueous antiperspirant c~nposi-tion comprising from about 15 to 25 percent by weight of an astringent ; material and from about 0.5 to 71 percent by weight of a lactate, citrate or tartrate ester of an cilkylene diol or triol.
In a preferred emkodiment, roll-on antiperspirant compositions are provided which comprise about 15 to 25 weight percent of an aluminum or aluminum-zirconium salt and about 0.5 to 71 weight percent of a lactate, citrate, or tartrate ester of an alkylene diol or triol, thereby improving the permeability of moisture through the normally difficultlypermeable coating surrounding the astringent particle.
The incorporation of the esters of the invention into the roll-on formuLations ~rov.ides faster on æ t of antiperspirant activity and higher maKumum efficacy at the 22-hour check point in clinical testiny, probably because the esters have a high dielectric constant, permitting moisture to more readily permeate -the coating around the astringent material. The esters are water so].uble, thereby el.iminating the need for emulsification, dispersing or solubilization. TfliS provides faster onset of activity and yet provides a dr.i.er Eeeling on the skin than with con~entional emollients.
The compositionSar.e nonstaining, less tacky, quick drying, and provide a desirable residual feelO With the proper choice of ingredient~s a nonwhiten-~2~72 ..
iny residue can be ohtained.
The antiperspirant roll-on comr positions contain a citrate, lactate, or tartrate ester of an alkylene diol or triol. r~hese esters include:
1,3-propylene glycol monolactate 1,3-propylene glycol dilactate 1,3-propylene glycol m~nocitrate 1,3-propylene glycol dicitrate 1,3~propylene glycol monotartrate 1,3-propylene glycol ditartrate 1,3-butylene glycol monolactate 1,3-butylene glycol dilactate 1,3-butylene glycol m~nocitrate 1,3-butylene glycol dicitrate 1,3-butylene glycol monotartrate 1,3-butylene glycol ditartrate glycerol monolactate glycerol dilactate glycerol ~onocitrate glycerol dicitrate glycerol monotartrate glycerol ditartrate glyceLol tritartrate, and the lik~.
The lactate esters are preferred becauæ of their more ready availability and ease of manufacture.
Active astrinyents may include ac~leous solutions of alum m um sulfate, al~num chloride, al~Nnum chlorohydrate, l .
or aluminum-zirconium hydroxy chloride. Combinations of aluminum chlorohydrate and al~inum chloride may also be used~
The preferred astringent is aluminum chlorohydra~e.
The esters of -the invention may be used in combina-tion with small amounts (0.5-8 weight percent) of other, more conventional emollients, or functional additives which may be added for reasons other than antiperspirant efficacy, such as thickeners, viscosity stabilizers, ~ragrance solubilizers, opacifiers, etc.
The compositions may also contain ethoxylated fatty alcohols, such as ethoxylated ~tearyl alcohol or ethoxylated stearic acid~ or ethoxylated cetyl or lauryl alcohol, or com-b~nations thereof, containing lO0 to 200 moles of combined ethylene oxide. Those containing high ethylene oxide content tend to be more permeable to moisture, thus further increasing antiperspirant onset and efficacy. The lower ethoxylated com-pounds, i.e., containing about 100 moles of ethylene oxide, are preferred. However, the esters of the invention may be used without the highly ethoxylated materials.
7~
Example 1 A roll~on composition was prepared havin~J the fol~
lowing ingredients:
Parts ~ Wei~ht Glyceryl monostearate 2.15 100 POE stearic acid 3.23 Magnesium aluminum silicate; acid stable 1.00 Aluminum chlorohydrate ~50% aqueous solution) 50.00 1,3-Propylene glycol monolactate 9.30 Fragrance 0-30 Dye color 0.02 Water 34.00 100. 00 *100 POE stearate is stearic acid : 15 ethoxylated with 100 moles of ethylene oxide.
, 7 ~ ~
F.xample 2 Roll-on antiperspirant formula~ions are prepared as follows:
Par~s by Wei~ht A B
Glyceryl monostearate 5.00 3.50 Magnesium aluminum silicate 0.50 1.00 100 POE stearyl alcohol5.00 3.50 Aluminum chlorohydrate (50%) 30.00 48.00 4 POE lauryl alcohol* 1.50 0.50 23 POE stearyl alcohol**4.50 1.50 Fragrance 1.00 0.00 1,3-Propylene glycol monolactate 8.00 ----1)3-Butylene glycol monolactate ---- 10.00 Water 44.50 32 00 100.00100.00 *lauryl alcohol condensed with an a~erage of ~ moles of ethylene oxide **stearyl alcohol condensed with an average of 23 moles o ethylene oxide . . ~ .
Example 3 Parts ~ Welght PPG stearyl ether (2) 4.70 PO~-2-stearyl ether 1.00 Alqminum chlorohydrate (50%) 50 00 POE-100 stearyl ether 1.00 Fragrance 0.30 - 1,3-Propylene glycol monolactate 20.00 Water 23.00 10~. 00 . , ,. .
Claims (6)
1. An aqueous antiperspirant composition comprising from about 15 to 25 percent by weight of an astringent material and from about 0.5 to 71 percent by weight of a lactate, citrate, or tartrate ester of an alkylene diol or triol.
2. The composition of Claim 1 comprising 1,3-pro-pylene glycol monolactate.
3. The composition of Claim 1 comprising 1,3-butylene glycol monolactate.
4. The composition of Claim 1 wherein said astrin-gent material is aluminum salt.
5. The composition of Claim 4 wherein said salt is aluminum chlorhydrate.
6. The composition of Claim 1 wherein said astrin-gent material is an aluminum-zirconium salt.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91542678A | 1978-06-14 | 1978-06-14 | |
| US915,426 | 1978-06-14 | ||
| ZA00801757A ZA801757B (en) | 1978-06-14 | 1980-03-25 | Antiperspirant compositions |
| GB8010336A GB2072503A (en) | 1978-06-14 | 1980-03-27 | Antiperspirant compositions |
| DE19803015450 DE3015450A1 (en) | 1978-06-14 | 1980-04-22 | ANTI-TRANSPIRANT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1121729A true CA1121729A (en) | 1982-04-13 |
Family
ID=27432525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000324948A Expired CA1121729A (en) | 1978-06-14 | 1979-04-05 | Citrate or lactate or tartrate of alkylene-ols in aqueous antiperspirant |
Country Status (4)
| Country | Link |
|---|---|
| CA (1) | CA1121729A (en) |
| DE (1) | DE3015450A1 (en) |
| GB (1) | GB2072503A (en) |
| ZA (1) | ZA801757B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4548808A (en) * | 1984-06-18 | 1985-10-22 | Leonard Chavkin | Long-acting anhydrous antiperspirant compositions containing triacetin |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT8167096A0 (en) * | 1981-01-26 | 1981-01-26 | Unilever Nv | COSMETIC STICK ESPECIALLY FOR THE TREATMENT OF ACNE |
| GB8302824D0 (en) * | 1983-02-02 | 1983-03-09 | Beecham Group Plc | Cosmetic |
| ZA843232B (en) * | 1983-05-03 | 1984-12-24 | Bristol Myers Co | Antiperspirant stick with low staining potential |
| US4552753A (en) * | 1983-12-01 | 1985-11-12 | The Procter & Gamble Company | Process for making roll-on antiperspirant compositions |
| JP5079302B2 (en) * | 2006-10-26 | 2012-11-21 | 花王株式会社 | 1,3-propanediol or a lactic acid ester derivative thereof |
| DE102009002097A1 (en) | 2009-04-01 | 2010-10-07 | Henkel Ag & Co. Kgaa | Antiperspirant sprays with ester oils |
| DE102009043004A1 (en) | 2009-09-28 | 2011-03-31 | Beiersdorf Ag | Aerosol preparations with stabilized particulate matter |
| DE102016000191A1 (en) | 2015-07-21 | 2017-01-26 | Beiersdorf Ag | Sweat-reducing preparation comprising hydroxycarboxylic acids and polyquaternium polymers |
-
1979
- 1979-04-05 CA CA000324948A patent/CA1121729A/en not_active Expired
-
1980
- 1980-03-25 ZA ZA00801757A patent/ZA801757B/en unknown
- 1980-03-27 GB GB8010336A patent/GB2072503A/en not_active Withdrawn
- 1980-04-22 DE DE19803015450 patent/DE3015450A1/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4548808A (en) * | 1984-06-18 | 1985-10-22 | Leonard Chavkin | Long-acting anhydrous antiperspirant compositions containing triacetin |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3015450A1 (en) | 1981-10-29 |
| ZA801757B (en) | 1981-03-25 |
| GB2072503A (en) | 1981-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1325599C (en) | Cosmetic composition | |
| US4435382A (en) | Anhydrous alcoholic antiperspirant suspension composition containing certain aluminum or aluminum/zirconium salt glycine complexes | |
| DE2211188C3 (en) | Anhydrous aerosol antiperspirant and process for its preparation | |
| EP2400945B1 (en) | Use of charged surfactants for reducing textile staining by antiperspirants | |
| US4151272A (en) | Wax-like antiperspirant stick compositions | |
| US2492085A (en) | Aluminum chlorohydrate astringent | |
| US2893918A (en) | Deodorant composition | |
| CA1121729A (en) | Citrate or lactate or tartrate of alkylene-ols in aqueous antiperspirant | |
| US4675177A (en) | Antiperspirant compositions | |
| DE3120742C2 (en) | ||
| JPH09506599A (en) | Deodorant formulation | |
| US5766578A (en) | Axillary malodor neutralization | |
| US4732754A (en) | Method for the preparation of antiperspirant compositions having enhanced efficacy | |
| AU609709B2 (en) | Method of neutralizing malodor derived from axilla | |
| US2889253A (en) | Zirconium containing anti-perspirant compositions | |
| JP2863405B2 (en) | Cosmetic composition | |
| DE2456639A1 (en) | Sprayable ester contg deodorant compsn - prevents container corrosion without reducing bacteriostatic activity | |
| US3235458A (en) | Process for preparing an aluminum sulfate-aluminum chlorhydrate antiperspirant cream | |
| EP0016533B1 (en) | Anti-perspirant compositions | |
| US20210299009A1 (en) | Silicone oil free antiperspirants | |
| US3499961A (en) | Dimethyl sulfoxide-enhanced astringent aluminum,zinc or zirconium antiperspirant salt cosmetics | |
| DE2358121A1 (en) | DESODORANS | |
| JPS631283B2 (en) | ||
| JPH05112441A (en) | Skin cosmetic | |
| KR20200136447A (en) | Skin symptom improvement agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |